Transcriptional changes in multiple system atrophy and Parkinson's disease putamen

Experimental Neurology
Ina R VogtUllrich Wüllner

Abstract

Multiple system atrophy (MSA) and sporadic, non-mendelian Parkinson's disease (PD) are progressive neurodegenerative disorders with overlapping clinical symptoms and pathology. The etiology of both disorders is unknown, and complex combinations of multiple susceptibility genes and environmental factors are thought to be involved. Both disorders are characterized by ubiquitous alpha-synuclein aggregates in distinct regions and cell types of the central nervous system. In PD, alpha-synuclein-positive aggregates appear to be largely neuronal while in MSA oligodendroglial inclusions prevail. In PD patients, the alpha-synuclein pathology is thought to evolve in a rather regular pattern, starting in the brainstem and olfactory bulb and extending gradually onto the substantia nigra and ultimately the cerebral cortex while the cerebellum is largely spared. MSA pathology has not been graded in a similar way yet; neuropathological analyses revealed neurodegeneration and gliosis primarily in the brainstem, midbrain and basal ganglia and the cerebellum, while the cortex is largely spared. To identify disease-specific transcriptional patterns in MSA, we chose CNS regions differentially affected in MSA and PD for comparative gene expression ...Continue Reading

References

Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Jun 24, 2003·Neuron·Zia RahmanEric J Nestler
Sep 1, 2004·Cell and Tissue Research·Heiko BraakKelly Del Tredici
Sep 10, 2004·Molecular Biology of the Cell·Freddy JeanneteauPierre Sokoloff
Nov 19, 2004·Journal of Neurology, Neurosurgery, and Psychiatry·S HelisalmiH Soininen
Dec 24, 2004·Journal of Cell Science·Stuart IrwinRay Truant
Jul 12, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Daniel G HealyUNKNOWN European MSA Study Group

❮ Previous
Next ❯

Citations

Oct 17, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·C Anthony AltarStephen D Ginsberg
Aug 15, 2012·Nature Reviews. Neurology·Johnathan Cooper-KnockPamela J Shaw
Oct 12, 2010·Science Translational Medicine·Bin ZhengUNKNOWN Global PD Gene Expression (GPEX) Consortium
Mar 24, 2009·PloS One·Greg T SutherlandGeorge D Mellick
Oct 27, 2015·International Journal of Molecular Sciences·Sonja W Scholz, Jose Bras
Feb 8, 2014·Acta Neuropathologica Communications·Jonathan M BleaselWoojin Scott Kim
Sep 5, 2014·Acta Neuropathologica Communications·Matthew D LiPurvesh Khatri
Feb 18, 2015·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Monica FederoffAndrew Singleton
Sep 25, 2014·Frontiers in Cellular Neuroscience·Andrii DomanskyiIlya A Vinnikov
Sep 29, 2011·Neurobiology of Disease·Teresa Botta-OrfilaMario Ezquerra
Jan 6, 2017·Cell Death & Disease·Marta CodrichStefano Gustincich
Feb 14, 2015·Molecular Neurobiology·Cornelius J H M KlemannJasper E Visser
Sep 8, 2007·The American Journal of Pathology·Yun Ju C SongPoul H Jensen
Sep 1, 2014·Journal of Molecular Neuroscience : MN·Michael J HurleyDavid T Dexter
May 29, 2009·Annals of Neurology·Sonja W ScholzThomas Gasser
Oct 27, 2017·The European Journal of Neuroscience·Genevie BorrageiroSoraya Bardien

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Basal ganglia in Parkinson's disease (MDS)

The basal ganglia is comprised of the neostriatum, the external and internal pallidal segments, the subthalamic nucleus, the substantia nigra pars reticulata, and the pars compacta of the substantia nigra. The basal ganglia circuitry is responsible for the correct execution of voluntary movements and is implicated in Parkinson's disease. Here is the latest research investigating the basal ganglia in Parkinson's disease.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.